Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings

Guidance for healthcare professionals who have the potential for direct or indirect exposure to patients or infectious materials. 2019 Novel Coronavirus SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up to 80% off … Read more…

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) – United States, 2018-19 Influenza Season

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) – United States, 2018-19 Influenza Season Seasonal Flu SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up to 80% off … Read more…

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) – United States, 2018-19 Influenza Season

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) – United States, 2018-19 Influenza Season Seasonal Flu SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up to 80% off … Read more…

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices

This report updates the 2017-18 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2017;66[No. RR-2]). Routine annual influenza vaccination is recommended for all persons aged … Read more…

The recommendations aim to keep health care workers and others at work — even if they might have been exposed to the virus

Newsletter | Podcast | Q&A | Tell us about those you’ve lost CNN.com – RSS Channel – HP Hero SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up to 80% off of your … Read more…